Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis

BACKGROUND: Dimethyl fumarate and fingolimod are oral disease modifying treatments (DMTs) that reduce relapse activity and slow disability worsening in relapsing–remitting multiple sclerosis (RRMS). OBJECTIVE: To compare the effectiveness of dimethyl fumarate and fingolimod in a real-world setting,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Neurol
Asıl Yazarlar: Lorscheider, Johannes, Benkert, Pascal, Lienert, Carmen, Hänni, Peter, Derfuss, Tobias, Kuhle, Jens, Kappos, Ludwig, Yaldizli, Özgür
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2020
Konular:
Original Communication
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914245/
https://ncbi.nlm.nih.gov/pubmed/32974794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-020-10226-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller